Skip to content

tufts center for the study of drug development

Running a Study 2 Minute Read

COVID Leads to Pivotal Changes in Clinical Research Industry

Over the past four months, COVID has led to widespread changes across the clinical research industry, many of which will be carried forwards. 1. Changes in Clinical Trial Protocol & Design According to data collected by the Tufts Center for the Study of Drug Development (CSDD), as of May 20, 2020, more than half of...

Get articles delivered to your inbox, every week